Início › Síndromes Mielodisplásicas › Distrito de Columbia › Washington
Ensaios clínicos de Síndromes Mielodisplásicas em Washington, DC
20 estudos para Síndromes Mielodisplásicas estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecrutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
CHIP/CCUS Natural History Protocol
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Natural History Study of GATA2 Deficiency and Related Disorders
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Tissue Samples for Cancer Research
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
RecrutandoFase 2
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · a 7 mi de distância
Mosaic Trial for Stem Cell Transplant Recipients
Recrutando
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecrutandoFase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi de distância
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi de distância
Ensaios de Síndromes Mielodisplásicas em outras cidades
- Houston, TX43 estudos
- Baldwin Park, CA26 estudos
- New York City, NY21 estudos
- Seattle, WA21 estudos
- Tampa, FL19 estudos
- Boston, MA19 estudos
- Miami, FL17 estudos
- Columbus, OH14 estudos
- Durham, NC14 estudos
- St. Louis, MO13 estudos
- Atlanta, GA13 estudos
- Chicago, IL13 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Câncer de Próstata38 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Câncer de Ovário23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.